Sofinnova Investments, Inc. Tg Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

$1.8 Billion
Q2 2024

A detailed history of Sofinnova Investments, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 1,861,277 shares of TGTX stock, worth $41 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

1,861,277

Previous 1,984,962 6.23%

Holding current value

$41 Million

Previous $30.2 Million 9.68%

% of portfolio

1.84%

Previous 1.76%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$13.32 - $19.19 $1.65 Million - $2.37 Million	-123,685 Reduced 6.23%	1,861,277 $33.1 Million
Q1 2024 Aug 14, 2024	BUY	$13.02 - $21.3 $1.61 Million - $2.63 Million	123,685 Added 6.65%	1,984,962 $30.2 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $25.8 Million - $42.3 Million	1,984,962 New	1,984,962 $30.2 Million
Q1 2021 May 14, 2021	SELL	$41.61 - $54.3 $2.72 Million - $3.56 Million	-65,474 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $4.67 Million - $10.2 Million	-184,927 Reduced 73.85%	65,474 $3.41 Million
Q3 2020 Nov 13, 2020	SELL	$18.49 - $27.24 $8.25 Million - $12.1 Million	-445,989 Reduced 64.04%	250,401 $6.7 Million
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $3.75 Million - $9.2 Million	421,085 Added 152.95%	696,390 $13.6 Million
Q1 2020 May 13, 2020	SELL	$7.14 - $15.99 $3.83 Million - $8.57 Million	-535,987 Reduced 66.07%	275,305 $2.71 Million
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $4.7 Million - $10.3 Million	-922,336 Reduced 53.2%	811,292 $9.01 Million
Q3 2019 Nov 14, 2019	BUY	$5.38 - $8.99 $2.54 Million - $4.25 Million	472,244 Added 37.44%	1,733,628 $9.73 Million
Q2 2019 Aug 13, 2019	BUY	$6.27 - $8.65 $5.7 Million - $7.87 Million	909,573 Added 258.54%	1,261,384 $10.9 Million
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $1.41 Million - $2.83 Million	351,811 New	351,811 $2.83 Million

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.2B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account

Sofinnova Investments, Inc. Tg Therapeutics, Inc. Transaction History